Beijing Zhongke WengeAI Science and Technology Co., Ltd. (“WENGE AI”) has completed its Global Offering of 14.83 million H shares at HK$60.70 each, generating gross proceeds of HK$900.50 million and estimated net proceeds of HK$826.90 million. Dealings in the shares are scheduled to begin on 26 June 2026.

The Hong Kong Public Offering, initially 5 % of the deal, was reallocated to 20 % after receiving 195,072 valid applications and 5,966.78 times subscription. The tranche now totals 2.97 million shares. The International Offering, subscribed 20.70 times by 147 placees, now comprises 11.87 million shares. An over-allotment option of up to 1.34 million shares remains available.

Six cornerstone investors—led by China Orient Enhanced Income Fund and Harvest Global Investments—took 4.00 million shares, equal to 26.97 % of the International Offering and 2.31 % of the enlarged share capital.

Post-listing, WENGE AI will have 173.10 million shares outstanding. Public shareholders will hold 71.97 % of total issued capital, exceeding the 15 % requirement. Nevertheless, concentration is high: the top 25 shareholders will control 91.23 % of the company, prompting the company to caution investors about potential share-price volatility on low trading volumes.

Lock-up commitments cover 39.31 % of the enlarged capital held by key persons, including founder Dr. Wang Lei and affiliated employee platforms, until 25 June 2027. Pathfinder strategic investors representing 12.79 % are locked up for six months, while cornerstone investors are restricted until 25 December 2026.

Shares will trade in board lots of 200 under stock code 01956. The stabilising period may run through 23 July 2026, subject to the discretion of China International Capital Corporation Hong Kong Securities as Stabilising Manager.